4,312 Shares in Globe Life Inc. $GL Acquired by Strategy Asset Managers LLC

Strategy Asset Managers LLC purchased a new stake in shares of Globe Life Inc. (NYSE:GL – Free Report) in the 3rd quarter, Holdings Channel.com reports. The firm purchased 4,312 shares of the company’s stock, valued at approximately $714,000.

Other large investors have also added to or reduced their stakes in the company. Contravisory Investment Management Inc. increased its stake in Globe Life by 4.3% in the 3rd quarter. Contravisory Investment Management Inc. now owns 6,782 shares of the company’s stock worth $1,123,000 after acquiring an additional 282 shares during the last quarter. NorthCrest Asset Manangement LLC boosted its position in shares of Globe Life by 8.6% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 1,937 shares of the company’s stock valued at $322,000 after acquiring an additional 154 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Globe Life by 2.4% during the 3rd quarter. GAMMA Investing LLC now owns 7,943 shares of the company’s stock valued at $1,316,000 after acquiring an additional 189 shares during the last quarter. Westwind Capital boosted its position in shares of Globe Life by 5.7% during the 3rd quarter. Westwind Capital now owns 10,187 shares of the company’s stock valued at $1,687,000 after acquiring an additional 545 shares during the last quarter. Finally, QRG Capital Management Inc. grew its holdings in shares of Globe Life by 16.7% in the second quarter. QRG Capital Management Inc. now owns 7,790 shares of the company’s stock valued at $1,392,000 after purchasing an additional 1,113 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Analyst Ratings Changes

GL has been the topic of several research reports. Piper Sandler boosted their price target on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. Morgan Stanley lowered their price objective on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a research report on Monday, October 5th. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Finally, Keefe, Bruyette & Woods reduced their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $190.22.

Read Our Latest Research Report on Globe Life

Insider Activity

In other news, CFO Thomas Kalmbach sold 21,000 shares of the firm’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,105,274.08. This trade represents a 29.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James Darden sold 50,000 shares of Globe Life stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 143,650 shares of company stock worth $25,793,717 over the last 90 days. Insiders own 2.11% of the company’s stock.

Globe Life Stock Performance

NYSE:GL opened at $167.43 on Thursday. The stock’s fifty day moving average is $172.11 and its 200 day moving average is $166.02. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The firm has a market capitalization of $12.87 billion, a PE ratio of 11.12 and a beta of 0.44. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts anticipate that Globe Life Inc. will post 15.70 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Globe Life declared that its board has approved a share repurchase plan on Monday, August 10th that allows the company to buy back $2.50 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 17.7% of its shares through open market purchases. Share buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Globe Life Profile

(Free Report)

Globe Life Inc (NYSE: GL) is an insurance holding company that provides life and supplemental health insurance products to individuals and families in the United States. Its offerings include term and whole life insurance, mortgage protection coverage, accident and supplemental health policies, and Medicare supplement insurance.

The company distributes its products through a network of insurance agencies, independent agents, and direct-to-consumer channels. Its principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, and Family Heritage Life Insurance Company.

Recommended Stories

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.